TR-14035 50mg | ≥99%
CSNpharm
TR-14035 is a dual antagonist of both integrin α4β7 and integrin α4β1 with IC50 values of 7 nM and 87 nM, respectively, used as an anti-inflammatory agent.
More Information Supplier PageTR-14035
Search Results
TR-14035 5mg | ≥99%
CSNpharm
TR-14035 is a dual antagonist of both integrin α4β7 and integrin α4β1 with IC50 values of 7 nM and 87 nM, respectively, used as an anti-inflammatory agent.
More Information Supplier PageTR-14035
TR-14035 10mg | ≥99%
CSNpharm
TR-14035 is a dual antagonist of both integrin α4β7 and integrin α4β1 with IC50 values of 7 nM and 87 nM, respectively, used as an anti-inflammatory agent.
More Information Supplier PageTR-14035
TR-14035 100mg | ≥99%
CSNpharm
TR-14035 is a dual antagonist of both integrin α4β7 and integrin α4β1 with IC50 values of 7 nM and 87 nM, respectively, used as an anti-inflammatory agent.
More Information Supplier PageTR-14035
MK-1775 5mg | ≥98%
CSNpharm
MK-1775 is a selective inhibitor of Wee1 with IC50 of 5.2 nM and blocks G2 DNA damage checkpoint.
More Information Supplier PageMK-1775
MK-1775 50mg | ≥98%
CSNpharm
MK-1775 is a selective inhibitor of Wee1 with IC50 of 5.2 nM and blocks G2 DNA damage checkpoint.
More Information Supplier PageMK-1775
MK-1775 10mg | ≥98%
CSNpharm
MK-1775 is a selective inhibitor of Wee1 with IC50 of 5.2 nM and blocks G2 DNA damage checkpoint.
More Information Supplier PageMK-1775
MK-1775 100mg | ≥98%
CSNpharm
MK-1775 is a selective inhibitor of Wee1 with IC50 of 5.2 nM and blocks G2 DNA damage checkpoint.
More Information Supplier PageMK-1775
MK-1775 1mg | ≥98%
CSNpharm
MK-1775 is a selective inhibitor of Wee1 with IC50 of 5.2 nM and blocks G2 DNA damage checkpoint.
More Information Supplier PageMK-1775
Pomalidomide 50mg | ≥99%
CSNpharm
Pomalidomide can inhibit LPS-induced TNF-α release with IC50 of 13 nM in PBMCs.
More Information Supplier PagePomalidomide
